Particle.news
Download on the App Store

Mexico Pivots to Prevention as Health Ministry Plans Insulin Glargine Procurement for 2027–2028

Early diagnosis with sustained lifestyle changes can markedly cut the chance of progression.

Overview

  • The federal health sector will transition to purchasing off‑patent insulin glargine in 2027–2028 as part of a modernization of diabetes treatment aligned with national clinical protocols, according to SSA official Eduardo Clark.
  • Health Secretary David Kershenobich said timely detection and targeted prevention can lower the risk of developing diabetes by about 40–60%, countering the idea that complications are inevitable after diagnosis.
  • Reported prediabetes thresholds include fasting glucose of 100–125 mg/dl and post‑meal values of 140–199 mg/dl, prompting calls for routine screening to intervene before disease onset.
  • Risk factors highlighted by officials include elevated fasting glucose, increased abdominal circumference, high‑calorie ultraprocessed diets, chronic stress, sleep disturbances, and a lack of preventive habits, which can raise probability by 20–60% and bring onset 5–10 years earlier.
  • Family history increases risk two to three times—rising to four to six times with two close relatives—while a history of gestational diabetes raises a woman's later risk seven to ten times and warrants postpartum follow‑up.